News
Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction. The sector has bounced back from a difficult 2024 and is ...
Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will have a harder ...
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon expected to pull back from the biotech industry, representing a blow to a ...
allowing the Chinese government to “control a global supply chain”, the commission said, adding that WuXi AppTec was the “Huawei equivalent for biotechnology”.
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...
While researchers discovered IgE antibodies all the way back in 1966, and biologics pioneers considered them at the birth of the biotech industry, Epsilogen claims its candidate is the world’s ...
Biotech Analyst Goonewardene, along with head and neck key opinion leader Dr. Perez (Sarah Cannon) (relevant companies MRUS BCAX EXEL) participate in an Analyst/Industry conference call to be held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results